Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 3,900 shares, an increase of 143.8% from the September 30th total of 1,600 shares. Based on an average daily volume of 49,900 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are short sold. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 49,900 shares, the days-to-cover ratio is currently 0.1 days.
Analyst Upgrades and Downgrades
Separately, Zacks Research cut Novozymes A/S from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 25th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy”.
Get Our Latest Research Report on Novozymes A/S
Novozymes A/S Trading Down 1.1%
Novozymes A/S Cuts Dividend
The business also recently declared a dividend, which was paid on Thursday, September 11th. Investors of record on Wednesday, September 3rd were paid a $0.1856 dividend. The ex-dividend date of this dividend was Tuesday, September 2nd. This represents a yield of 88.0%. Novozymes A/S’s dividend payout ratio (DPR) is currently 21.76%.
Novozymes A/S Company Profile
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Featured Articles
- Five stocks we like better than Novozymes A/S
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Amazon Earnings: 3 Catalysts That Could Drive Shares to $300
- What is the S&P/TSX Index?
- Why Chipotle Stock May Bounce After a Brutal Sell-Off
- How to Invest in the FAANG Stocks
- Why VGT May Be a Smarter Bet Than Chasing Individual Tech Stocks
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
